Hospitalogy November 12, 2024
Blake Madden

Drug Distributors continue Vertical Integration Strategy as Cencora, Cardinal make Big Bets

Deals among PE-backed physician practice management players and strategic buyers (drug distributors in this case) are heating up.

On November 6, Cencora bought Retina Consultants of America (RCA) for $4.6B (an 85% stake and $500M in incentive payments).

  • RCA serves 300+ retina specialists in 23 states and sees 2 million patient visits annually.
  • Interestingly RCA specializes in clinical trials in research, which Cencora is sure to have an invested (literally) interest in.
  • Through eventually owning both OneOncology and RCA, Cencora will look to build out a more integrated management services organization (an MSO, as our industry so fondly loves its acronym) to house its services subsidiary.
...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: CMS, Govt Agencies, Health System / Hospital, Insurance, Medicare, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Physician, Provider, Trends
Why Walgreens Specialty Pharmacy May Be Its Most Desirable Asset
Pharma Pulse 3/3/25: Will Tariffs Affect Branded Drug Prices? Pharmacists' Role in Medical Cannabis Counseling and Patient Education & more
Pharma’s Role in Ensuring Patient Access to Trustworthy Health Insights
AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic
How Pharmaceutical Companies Can Mitigate a Potential Drop in Demand Due to Tariffs

Share This Article